 | • レポートコード：D0GIR-00972 • 出版社/出版日：GlobalInfoResearch / 2020年9月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、新生児および出生前遺伝子検査の世界市場を広く調査・分析し、今後の市場展望をまとめております。新生児および出生前遺伝子検査の種類別市場規模（PCR、FISH、aCGH、NIPT、MSS）、用途別市場規模（病院、クリニック、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Perkin Elmer、Ariosa Diagnostics、Agilent Technologies, Inc.、Verinata Health、Illumina, Inc.、Sequenom, Inc.、CapitalBio MedLab、Natera, Inc.、Bio-Rad Laboratories, Inc.、BGI ・地域別グローバル市場分析 2015年-2020年 ・新生児および出生前遺伝子検査の北米市場（アメリカ、カナダ、メキシコ） ・新生児および出生前遺伝子検査のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・新生児および出生前遺伝子検査のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・新生児および出生前遺伝子検査の南米市場（ブラジル、アルゼンチン） ・新生児および出生前遺伝子検査の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：PCR、FISH、aCGH、NIPT、MSS ・用途別分析：病院、クリニック、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The Newborn and Prenatal Genetic Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The most likely (base case) scenario is that the global Newborn and Prenatal Genetic Testing sales will be xx in 2020 from Newborn and Prenatal Genetic Testing million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Newborn and Prenatal Genetic Testing market size is expected to grow at xx% or more annually for the next five years.
This report also researches and evaluates the impact of Covid-19 outbreak on the Newborn and Prenatal Genetic Testing industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Newborn and Prenatal Genetic Testing and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Market segmentation
Newborn and Prenatal Genetic Testing market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Newborn and Prenatal Genetic Testing market has been segmented into:
PCR
FISH
aCGH
NIPT
MSS
By Application, Newborn and Prenatal Genetic Testing has been segmented into:
Hospital
Clinic
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Newborn and Prenatal Genetic Testing market presented in the report. This section sheds light on the sales growth of different regional and country-level Newborn and Prenatal Genetic Testing markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Newborn and Prenatal Genetic Testing market.
The report offers in-depth assessment of the growth and other aspects of the Newborn and Prenatal Genetic Testing market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Newborn and Prenatal Genetic Testing Market Share Analysis
Newborn and Prenatal Genetic Testing competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Newborn and Prenatal Genetic Testing sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Newborn and Prenatal Genetic Testing sales, revenue and market share for each player covered in this report.
The major players covered in Newborn and Prenatal Genetic Testing are:
Perkin Elmer
Ariosa Diagnostics
Agilent Technologies, Inc.
Verinata Health
Illumina, Inc.
Sequenom, Inc.
CapitalBio MedLab
Natera, Inc.
Bio-Rad Laboratories, Inc.
BGI
Among other players domestic and global, Newborn and Prenatal Genetic Testing market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 Newborn and Prenatal Genetic Testing Market Overview
1.1 Product Overview and Scope of Newborn and Prenatal Genetic Testing
1.2 Classification of Newborn and Prenatal Genetic Testing by Type
1.2.1 Global Newborn and Prenatal Genetic Testing Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Newborn and Prenatal Genetic Testing Revenue Market Share by Type in 2019
1.2.3 PCR
1.2.4 FISH
1.2.5 aCGH
1.2.6 NIPT
1.2.7 MSS
1.3 Global Newborn and Prenatal Genetic Testing Market by Application
1.3.1 Overview: Global Newborn and Prenatal Genetic Testing Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Newborn and Prenatal Genetic Testing Market by Regions
1.4.1 Global Newborn and Prenatal Genetic Testing Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Newborn and Prenatal Genetic Testing (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Newborn and Prenatal Genetic Testing Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Newborn and Prenatal Genetic Testing Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Newborn and Prenatal Genetic Testing Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Newborn and Prenatal Genetic Testing Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Newborn and Prenatal Genetic Testing Status and Prospect (2015-2025)
1.5 COVID-19 Outbreak: Newborn and Prenatal Genetic Testing Industry Impact
1.5.1 COVID-19 Potential Implications for the Newborn and Prenatal Genetic Testing
1.5.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Newborn and Prenatal Genetic Testing
1.5.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.5.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.5.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.5.2 Opportunity Analysis in Covid-19 Crisis
1.5.3 Market Risk and Restraints
1.5.4 Market Driving Force
2 Company Profiles
2.1 Perkin Elmer
2.1.1 Perkin Elmer Details
2.1.2 Perkin Elmer Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Perkin Elmer SWOT Analysis
2.1.4 Perkin Elmer Product and Services
2.1.5 Perkin Elmer Newborn and Prenatal Genetic Testing Revenue, Gross Margin and Market Share (2018-2019)
2.2 Ariosa Diagnostics
2.2.1 Ariosa Diagnostics Details
2.2.2 Ariosa Diagnostics Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Ariosa Diagnostics SWOT Analysis
2.2.4 Ariosa Diagnostics Product and Services
2.2.5 Ariosa Diagnostics Newborn and Prenatal Genetic Testing Revenue, Gross Margin and Market Share (2018-2019)
2.3 Agilent Technologies, Inc.
2.3.1 Agilent Technologies, Inc. Details
2.3.2 Agilent Technologies, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Agilent Technologies, Inc. SWOT Analysis
2.3.4 Agilent Technologies, Inc. Product and Services
2.3.5 Agilent Technologies, Inc. Newborn and Prenatal Genetic Testing Revenue, Gross Margin and Market Share (2018-2019)
2.4 Verinata Health
2.4.1 Verinata Health Details
2.4.2 Verinata Health Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Verinata Health SWOT Analysis
2.4.4 Verinata Health Product and Services
2.4.5 Verinata Health Newborn and Prenatal Genetic Testing Revenue, Gross Margin and Market Share (2018-2019)
2.5 Illumina, Inc.
2.5.1 Illumina, Inc. Details
2.5.2 Illumina, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Illumina, Inc. SWOT Analysis
2.5.4 Illumina, Inc. Product and Services
2.5.5 Illumina, Inc. Newborn and Prenatal Genetic Testing Revenue, Gross Margin and Market Share (2018-2019)
2.6 Sequenom, Inc.
2.6.1 Sequenom, Inc. Details
2.6.2 Sequenom, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Sequenom, Inc. SWOT Analysis
2.6.4 Sequenom, Inc. Product and Services
2.6.5 Sequenom, Inc. Newborn and Prenatal Genetic Testing Revenue, Gross Margin and Market Share (2018-2019)
2.7 CapitalBio MedLab
2.7.1 CapitalBio MedLab Details
2.7.2 CapitalBio MedLab Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 CapitalBio MedLab SWOT Analysis
2.7.4 CapitalBio MedLab Product and Services
2.7.5 CapitalBio MedLab Newborn and Prenatal Genetic Testing Revenue, Gross Margin and Market Share (2018-2019)
2.8 Natera, Inc.
2.8.1 Natera, Inc. Details
2.8.2 Natera, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Natera, Inc. SWOT Analysis
2.8.4 Natera, Inc. Product and Services
2.8.5 Natera, Inc. Newborn and Prenatal Genetic Testing Revenue, Gross Margin and Market Share (2018-2019)
2.9 Bio-Rad Laboratories, Inc.
2.9.1 Bio-Rad Laboratories, Inc. Details
2.9.2 Bio-Rad Laboratories, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Bio-Rad Laboratories, Inc. SWOT Analysis
2.9.4 Bio-Rad Laboratories, Inc. Product and Services
2.9.5 Bio-Rad Laboratories, Inc. Newborn and Prenatal Genetic Testing Revenue, Gross Margin and Market Share (2018-2019)
2.10 BGI
2.10.1 BGI Details
2.10.2 BGI Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 BGI SWOT Analysis
2.10.4 BGI Product and Services
2.10.5 BGI Newborn and Prenatal Genetic Testing Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Newborn and Prenatal Genetic Testing Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Newborn and Prenatal Genetic Testing Players Market Share
3.2.2 Top 10 Newborn and Prenatal Genetic Testing Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Newborn and Prenatal Genetic Testing Revenue and Market Share by Regions
4.2 North America Newborn and Prenatal Genetic Testing Revenue and Growth Rate (2015-2020)
4.3 Europe Newborn and Prenatal Genetic Testing Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Newborn and Prenatal Genetic Testing Revenue and Growth Rate (2015-2020)
4.5 South America Newborn and Prenatal Genetic Testing Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Newborn and Prenatal Genetic Testing Revenue and Growth Rate (2015-2020)
5 North America Newborn and Prenatal Genetic Testing Revenue by Countries
5.1 North America Newborn and Prenatal Genetic Testing Revenue by Countries (2015-2020)
5.2 USA Newborn and Prenatal Genetic Testing Revenue and Growth Rate (2015-2020)
5.3 Canada Newborn and Prenatal Genetic Testing Revenue and Growth Rate (2015-2020)
5.4 Mexico Newborn and Prenatal Genetic Testing Revenue and Growth Rate (2015-2020)
6 Europe Newborn and Prenatal Genetic Testing Revenue by Countries
6.1 Europe Newborn and Prenatal Genetic Testing Revenue by Countries (2015-2020)
6.2 Germany Newborn and Prenatal Genetic Testing Revenue and Growth Rate (2015-2020)
6.3 UK Newborn and Prenatal Genetic Testing Revenue and Growth Rate (2015-2020)
6.4 France Newborn and Prenatal Genetic Testing Revenue and Growth Rate (2015-2020)
6.5 Russia Newborn and Prenatal Genetic Testing Revenue and Growth Rate (2015-2020)
6.6 Italy Newborn and Prenatal Genetic Testing Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Newborn and Prenatal Genetic Testing Revenue by Countries
7.1 Asia-Pacific Newborn and Prenatal Genetic Testing Revenue by Countries (2015-2020)
7.2 China Newborn and Prenatal Genetic Testing Revenue and Growth Rate (2015-2020)
7.3 Japan Newborn and Prenatal Genetic Testing Revenue and Growth Rate (2015-2020)
7.4 Korea Newborn and Prenatal Genetic Testing Revenue and Growth Rate (2015-2020)
7.5 India Newborn and Prenatal Genetic Testing Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Newborn and Prenatal Genetic Testing Revenue and Growth Rate (2015-2020)
8 South America Newborn and Prenatal Genetic Testing Revenue by Countries
8.1 South America Newborn and Prenatal Genetic Testing Revenue by Countries (2015-2020)
8.2 Brazil Newborn and Prenatal Genetic Testing Revenue and Growth Rate (2015-2020)
8.3 Argentina Newborn and Prenatal Genetic Testing Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Newborn and Prenatal Genetic Testing by Countries
9.1 Middle East & Africa Newborn and Prenatal Genetic Testing Revenue by Countries (2015-2020)
9.2 Saudi Arabia Newborn and Prenatal Genetic Testing Revenue and Growth Rate (2015-2020)
9.3 UAE Newborn and Prenatal Genetic Testing Revenue and Growth Rate (2015-2020)
9.4 Egypt Newborn and Prenatal Genetic Testing Revenue and Growth Rate (2015-2020)
9.5 South Africa Newborn and Prenatal Genetic Testing Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Newborn and Prenatal Genetic Testing Revenue and Market Share by Type (2015-2020)
10.2 Global Newborn and Prenatal Genetic Testing Market Forecast by Type (2019-2024)
10.3 PCR Revenue Growth Rate (2015-2025)
10.4 FISH Revenue Growth Rate (2015-2025)
10.5 aCGH Revenue Growth Rate (2015-2025)
10.6 NIPT Revenue Growth Rate (2015-2025)
10.7 MSS Revenue Growth Rate (2015-2025)
11 Global Newborn and Prenatal Genetic Testing Market Segment by Application
11.1 Global Newborn and Prenatal Genetic Testing Revenue Market Share by Application (2015-2020)
11.2 Newborn and Prenatal Genetic Testing Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2015-2020)
11.4 Clinic Revenue Growth (2015-2020)
11.5 Others Revenue Growth (2015-2020)
12 Global Newborn and Prenatal Genetic Testing Market Size Forecast (2021-2025)
12.1 Global Newborn and Prenatal Genetic Testing Market Size Forecast (2021-2025)
12.2 Global Newborn and Prenatal Genetic Testing Market Forecast by Regions (2021-2025)
12.3 North America Newborn and Prenatal Genetic Testing Revenue Market Forecast (2021-2025)
12.4 Europe Newborn and Prenatal Genetic Testing Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Newborn and Prenatal Genetic Testing Revenue Market Forecast (2021-2025)
12.6 South America Newborn and Prenatal Genetic Testing Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Newborn and Prenatal Genetic Testing Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Newborn and Prenatal Genetic Testing Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Newborn and Prenatal Genetic Testing by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Newborn and Prenatal Genetic Testing Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Newborn and Prenatal Genetic Testing Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Newborn and Prenatal Genetic Testing Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Perkin Elmer Corporate Information, Location and Competitors
Table 7. Perkin Elmer Newborn and Prenatal Genetic Testing Major Business
Table 8. Perkin Elmer Newborn and Prenatal Genetic Testing Total Revenue (USD Million) (2017-2018)
Table 9. Perkin Elmer SWOT Analysis
Table 10. Perkin Elmer Newborn and Prenatal Genetic Testing Product and Solutions
Table 11. Perkin Elmer Newborn and Prenatal Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Ariosa Diagnostics Corporate Information, Location and Competitors
Table 13. Ariosa Diagnostics Newborn and Prenatal Genetic Testing Major Business
Table 14. Ariosa Diagnostics Newborn and Prenatal Genetic Testing Total Revenue (USD Million) (2018-2019)
Table 15. Ariosa Diagnostics SWOT Analysis
Table 16. Ariosa Diagnostics Newborn and Prenatal Genetic Testing Product and Solutions
Table 17. Ariosa Diagnostics Newborn and Prenatal Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Agilent Technologies, Inc. Corporate Information, Location and Competitors
Table 19. Agilent Technologies, Inc. Newborn and Prenatal Genetic Testing Major Business
Table 20. Agilent Technologies, Inc. Newborn and Prenatal Genetic Testing Total Revenue (USD Million) (2017-2018)
Table 21. Agilent Technologies, Inc. SWOT Analysis
Table 22. Agilent Technologies, Inc. Newborn and Prenatal Genetic Testing Product and Solutions
Table 23. Agilent Technologies, Inc. Newborn and Prenatal Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Verinata Health Corporate Information, Location and Competitors
Table 25. Verinata Health Newborn and Prenatal Genetic Testing Major Business
Table 26. Verinata Health Newborn and Prenatal Genetic Testing Total Revenue (USD Million) (2017-2018)
Table 27. Verinata Health SWOT Analysis
Table 28. Verinata Health Newborn and Prenatal Genetic Testing Product and Solutions
Table 29. Verinata Health Newborn and Prenatal Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Illumina, Inc. Corporate Information, Location and Competitors
Table 31. Illumina, Inc. Newborn and Prenatal Genetic Testing Major Business
Table 32. Illumina, Inc. Newborn and Prenatal Genetic Testing Total Revenue (USD Million) (2017-2018)
Table 33. Illumina, Inc. SWOT Analysis
Table 34. Illumina, Inc. Newborn and Prenatal Genetic Testing Product and Solutions
Table 35. Illumina, Inc. Newborn and Prenatal Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Sequenom, Inc. Corporate Information, Location and Competitors
Table 37. Sequenom, Inc. Newborn and Prenatal Genetic Testing Major Business
Table 38. Sequenom, Inc. Newborn and Prenatal Genetic Testing Total Revenue (USD Million) (2017-2018)
Table 39. Sequenom, Inc. SWOT Analysis
Table 40. Sequenom, Inc. Newborn and Prenatal Genetic Testing Product and Solutions
Table 41. Sequenom, Inc. Newborn and Prenatal Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. CapitalBio MedLab Corporate Information, Location and Competitors
Table 43. CapitalBio MedLab Newborn and Prenatal Genetic Testing Major Business
Table 44. CapitalBio MedLab Newborn and Prenatal Genetic Testing Total Revenue (USD Million) (2017-2018)
Table 45. CapitalBio MedLab SWOT Analysis
Table 46. CapitalBio MedLab Newborn and Prenatal Genetic Testing Product and Solutions
Table 47. CapitalBio MedLab Newborn and Prenatal Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Natera, Inc. Corporate Information, Location and Competitors
Table 49. Natera, Inc. Newborn and Prenatal Genetic Testing Major Business
Table 50. Natera, Inc. Newborn and Prenatal Genetic Testing Total Revenue (USD Million) (2017-2018)
Table 51. Natera, Inc. SWOT Analysis
Table 52. Natera, Inc. Newborn and Prenatal Genetic Testing Product and Solutions
Table 53. Natera, Inc. Newborn and Prenatal Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. Bio-Rad Laboratories, Inc. Corporate Information, Location and Competitors
Table 55. Bio-Rad Laboratories, Inc. Newborn and Prenatal Genetic Testing Major Business
Table 56. Bio-Rad Laboratories, Inc. Newborn and Prenatal Genetic Testing Total Revenue (USD Million) (2017-2018)
Table 57. Bio-Rad Laboratories, Inc. SWOT Analysis
Table 58. Bio-Rad Laboratories, Inc. Newborn and Prenatal Genetic Testing Product and Solutions
Table 59. Bio-Rad Laboratories, Inc. Newborn and Prenatal Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. BGI Corporate Information, Location and Competitors
Table 61. BGI Newborn and Prenatal Genetic Testing Major Business
Table 62. BGI Newborn and Prenatal Genetic Testing Total Revenue (USD Million) (2017-2018)
Table 63. BGI SWOT Analysis
Table 64. BGI Newborn and Prenatal Genetic Testing Product and Solutions
Table 65. BGI Newborn and Prenatal Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. Global Newborn and Prenatal Genetic Testing Revenue (Million USD) by Players (2015-2020)
Table 67. Global Newborn and Prenatal Genetic Testing Revenue Share by Players (2015-2020)
Table 68. Global Newborn and Prenatal Genetic Testing Revenue (Million USD) by Regions (2015-2020)
Table 69. Global Newborn and Prenatal Genetic Testing Revenue Market Share by Regions (2015-2020)
Table 70. North America Newborn and Prenatal Genetic Testing Revenue by Countries (2015-2020)
Table 71. North America Newborn and Prenatal Genetic Testing Revenue Market Share by Countries (2015-2020)
Table 72. Europe Newborn and Prenatal Genetic Testing Revenue (Million USD) by Countries (2015-2020)
Table 73. Asia-Pacific Newborn and Prenatal Genetic Testing Revenue (Million USD) by Countries (2015-2020)
Table 74. South America Newborn and Prenatal Genetic Testing Revenue by Countries (2015-2020)
Table 75. South America Newborn and Prenatal Genetic Testing Revenue Market Share by Countries (2015-2020)
Table 76. Middle East and Africa Newborn and Prenatal Genetic Testing Revenue (Million USD) by Countries (2015-2020)
Table 77. Middle East and Africa Newborn and Prenatal Genetic Testing Revenue Market Share by Countries (2015-2020)
Table 78. Global Newborn and Prenatal Genetic Testing Revenue (Million USD) by Type (2015-2020)
Table 79. Global Newborn and Prenatal Genetic Testing Revenue Share by Type (2015-2020)
Table 80. Global Newborn and Prenatal Genetic Testing Revenue Forecast by Type (2021-2025)
Table 81. Global Newborn and Prenatal Genetic Testing Revenue by Application (2015-2020)
Table 82. Global Newborn and Prenatal Genetic Testing Revenue Share by Application (2015-2020)
Table 83. Global Newborn and Prenatal Genetic Testing Revenue Forecast by Application (2021-2025)
Table 84. Global Newborn and Prenatal Genetic Testing Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Newborn and Prenatal Genetic Testing Picture
Figure 2. Global Newborn and Prenatal Genetic Testing Revenue Market Share by Type in 2019
Figure 3. PCR Picture
Figure 4. FISH Picture
Figure 5. aCGH Picture
Figure 6. NIPT Picture
Figure 7. MSS Picture
Figure 8. Newborn and Prenatal Genetic Testing Revenue Market Share by Application in 2019
Figure 9. Hospital Picture
Figure 10. Clinic Picture
Figure 11. Others Picture
Figure 12. Global Newborn and Prenatal Genetic Testing Revenue (USD Million) and Growth Rate (2015-2025)
Figure 13. North America Newborn and Prenatal Genetic Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Europe Newborn and Prenatal Genetic Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Asia-Pacific Newborn and Prenatal Genetic Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. South America Newborn and Prenatal Genetic Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Middle East and Africa Newborn and Prenatal Genetic Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Newborn and Prenatal Genetic Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Newborn and Prenatal Genetic Testing Revenue Share by Players in 2019
Figure 20. Global Top 5 Players Newborn and Prenatal Genetic Testing Revenue Market Share in 2019
Figure 21. Global Top 10 Players Newborn and Prenatal Genetic Testing Revenue Market Share in 2019
Figure 22. Key Players Market Share Trend
Figure 23. Global Newborn and Prenatal Genetic Testing Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 24. Global Newborn and Prenatal Genetic Testing Revenue Market Share by Regions (2015-2020)
Figure 25. Global Newborn and Prenatal Genetic Testing Revenue Market Share by Regions in 2018
Figure 26. North America Newborn and Prenatal Genetic Testing Revenue and Growth Rate (2015-2020)
Figure 27. Europe Newborn and Prenatal Genetic Testing Revenue and Growth Rate (2015-2020)
Figure 28. Asia-Pacific Newborn and Prenatal Genetic Testing Revenue and Growth Rate (2015-2020)
Figure 29. South America Newborn and Prenatal Genetic Testing Revenue and Growth Rate (2015-2020)
Figure 30. Middle East and Africa Newborn and Prenatal Genetic Testing Revenue and Growth Rate (2015-2020)
Figure 31. North America Newborn and Prenatal Genetic Testing Revenue Market Share by Countries (2015-2020)
Figure 32. North America Newborn and Prenatal Genetic Testing Revenue Market Share by Countries in 2019
Figure 33. USA Newborn and Prenatal Genetic Testing Revenue and Growth Rate (2015-2020)
Figure 34. Canada Newborn and Prenatal Genetic Testing Revenue and Growth Rate (2015-2020)
Figure 35. Mexico Newborn and Prenatal Genetic Testing Revenue and Growth Rate (2015-2020)
Figure 36. Europe Newborn and Prenatal Genetic Testing Revenue Market Share by Countries (2015-2020)
Figure 37. Europe Newborn and Prenatal Genetic Testing Revenue Market Share by Countries in 2019
Figure 38. Germany Newborn and Prenatal Genetic Testing Revenue and Growth Rate (2015-2020)
Figure 39. UK Newborn and Prenatal Genetic Testing Revenue and Growth Rate (2015-2020)
Figure 40. France Newborn and Prenatal Genetic Testing Revenue and Growth Rate (2015-2020)
Figure 41. Russia Newborn and Prenatal Genetic Testing Revenue and Growth Rate (2015-2020)
Figure 42. Italy Newborn and Prenatal Genetic Testing Revenue and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Newborn and Prenatal Genetic Testing Revenue Market Share by Countries (2015-2020)
Figure 44. Asia-Pacific Newborn and Prenatal Genetic Testing Revenue Market Share by Countries in 2019
Figure 45. China Newborn and Prenatal Genetic Testing Revenue and Growth Rate (2015-2020)
Figure 46. Japan Newborn and Prenatal Genetic Testing Revenue and Growth Rate (2015-2020)
Figure 47. Korea Newborn and Prenatal Genetic Testing Revenue and Growth Rate (2015-2020)
Figure 48. India Newborn and Prenatal Genetic Testing Revenue and Growth Rate (2015-2020)
Figure 49. Southeast Asia Newborn and Prenatal Genetic Testing Revenue and Growth Rate (2015-2020)
Figure 50. South America Newborn and Prenatal Genetic Testing Revenue Market Share by Countries (2015-2020)
Figure 51. South America Newborn and Prenatal Genetic Testing Revenue Market Share by Countries in 2019
Figure 52. Brazil Newborn and Prenatal Genetic Testing Revenue and Growth Rate (2015-2020)
Figure 53. Argentina Newborn and Prenatal Genetic Testing Revenue and Growth Rate (2015-2020)
Figure 54. Middle East and Africa Newborn and Prenatal Genetic Testing Revenue Market Share by Countries (2015-2020)
Figure 55. Middle East and Africa Newborn and Prenatal Genetic Testing Revenue Market Share by Countries in 2019
Figure 56. Saudi Arabia Newborn and Prenatal Genetic Testing Revenue and Growth Rate (2015-2020)
Figure 57. UAE Newborn and Prenatal Genetic Testing Revenue and Growth Rate (2015-2020)
Figure 58. Egypt Newborn and Prenatal Genetic Testing Revenue and Growth Rate (2015-2020)
Figure 59. South Africa Newborn and Prenatal Genetic Testing Revenue and Growth Rate (2015-2020)
Figure 60. Global Newborn and Prenatal Genetic Testing Revenue Share by Type (2015-2020)
Figure 61. Global Newborn and Prenatal Genetic Testing Revenue Share by Type in 2019
Figure 62. Global Newborn and Prenatal Genetic Testing Market Share Forecast by Type (2021-2025)
Figure 63. Global PCR Revenue Growth Rate (2015-2020)
Figure 64. Global FISH Revenue Growth Rate (2015-2020)
Figure 65. Global aCGH Revenue Growth Rate (2015-2020)
Figure 66. Global NIPT Revenue Growth Rate (2015-2020)
Figure 67. Global MSS Revenue Growth Rate (2015-2020)
Figure 68. Global Newborn and Prenatal Genetic Testing Revenue Share by Application (2015-2020)
Figure 69. Global Newborn and Prenatal Genetic Testing Revenue Share by Application in 2019
Figure 70. Global Newborn and Prenatal Genetic Testing Market Share Forecast by Application (2021-2025)
Figure 71. Global Hospital Revenue Growth Rate (2015-2020)
Figure 72. Global Clinic Revenue Growth Rate (2015-2020)
Figure 73. Global Others Revenue Growth Rate (2015-2020)
Figure 74. Global Newborn and Prenatal Genetic Testing Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 75. Global Newborn and Prenatal Genetic Testing Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 76. Global Newborn and Prenatal Genetic Testing Revenue Market Share Forecast by Regions (2021-2025)
Figure 77. North America Newborn and Prenatal Genetic Testing Revenue Market Forecast (2021-2025)
Figure 78. Europe Newborn and Prenatal Genetic Testing Revenue Market Forecast (2021-2025)
Figure 79. Asia-Pacific Newborn and Prenatal Genetic Testing Revenue Market Forecast (2021-2025)
Figure 80. South America Newborn and Prenatal Genetic Testing Revenue Market Forecast (2021-2025)
Figure 81. Middle East and Africa Newborn and Prenatal Genetic Testing Revenue Market Forecast (2021-2025)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
出生前検査の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Prenatal Testing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Prenatal Testing market repo…- 遺伝病診断の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Genetic Disease Diagnostic market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Genetic Disease Di…
- 消費者向け遺伝子検査（DTC）の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Genetic Testing for Consumers (DTC) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain…
- 希少疾患遺伝子検査の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Rare Disease Genetic Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimi…
- 着床前遺伝子検査の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Preimplantation Genetic Testing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.5% in the forecast period of 2020 to 2025 and will expected to reach USD 428.6 million by 2025, from USD 345.5 million in 2019. The Preimp…